Minocycline (MIN) usually shows good activity against Acinetobacter baumannii strains. The reintroduction to the market of intravenous MIN provides an additional agent to the limited options for the treatment of A. baumannii infections. The activity of MIN as a single agent and in combination with rifampicin (RIF), colistin (COL) or imipenem (IMI) was evaluated by means of killing curves and 24 h-time-kill curves in five A. baumannii isolates which were selected on the basis of different antimicrobial resistance profiles. MIN showed bacteriostatic activity in three isolates (2 × or 16 × MIC) and bactericidal activity in the other isolates (64 × MIC). In isolates harbouring the tetB gene, the associations studied were always indifferent. However, in isolates not harbouring tetB, the use of MIN in combination showed a rapid synergistic effect (at 4 h) in four out of nine combinations (two with RIF and one each with IMI and COL). At 24 h, this effect was observed in six out of nine combinations (two in each association). MIN in combination with RIF, IMI and COL showed bactericidal synergy in most of the isolates which did not harbour the tetB gene, but the combinations were not synergistic in tetB-positive isolates.
BantarC.,
SchellC.,
PosseG.,
LimanskyA.,
BalleriniV.,
MobiliaL.2008; Comparative time-kill study of doxycycline, tigecycline, sulbactam, and imipenem against several clones of Acinetobacter baumannii
. Diagn Microbiol Infect Dis 61:309–314 [View Article][PubMed]
CastanheiraM.,
MendesR. E.,
JonesR. N.2014; Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options. Clin Infect Dis 59:(Suppl 6)S367–S373 [View Article][PubMed]
GoffD. A.,
KayeK. S.2014; Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii
. Clin Infect Dis 59:(Suppl 6)S365–S366 [View Article][PubMed]
HuysG.,
CnockaertM.,
VaneechoutteM.,
WoodfordN.,
NemecA.,
DijkshoornL.,
SwingsJ.2005; Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res Microbiol 156:348–355 [View Article][PubMed]
LiangW.,
LiuX. F.,
HuangJ.,
ZhuD. M.,
LiJ.,
ZhangJ.2011; Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients. BMC Infect Dis 11:109–116 [View Article][PubMed]
Members of the SFM Antibiogram Committee2003; Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003. Int J Antimicrob Agents 21:364–391[CrossRef]
SeifertH.,
DolzaniL.,
BressanR.,
van der ReijdenT.,
van StrijenB.,
StefanikD.,
HeersmaH.,
DijkshoornL.2005; Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii
. J Clin Microbiol 43:4328–4335 [View Article][PubMed]
WoodG. C.,
HanesS. D.,
BoucherB. A.,
CroceM. A.,
FabianT. C.2003; Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia. Intensive Care Med 29:2072–2076 [View Article][PubMed]